3 Selvom disse bivirkninger menes at være relateret til disse stoffers ergoline struktur, vides det ikke, om andre non- ergoline dopaminagonister kan forårsage dem.
3 Although these adverse reactions are believed to be related to the ergoline structure of these compounds, whether other, nonergot derived dopamine agonists can cause them is unknown.